Biomarker treatment for brain tumors studied
Tuesday, June 15, 2010 - 16:50
in Health & Medicine
The Brain Tumor Unit at the Moores UCSD Cancer Center at the University of California, San Diego, is launching a clinical trial that will examine the use of biomarkers to advance the treatment of malignant gliomas, brain tumors that start in the brain or spinal cord tissue. Annually, about 17,000 Americans are diagnosed with gliomas, which are difficult to treat and often fatal.